논문KCI 등재
Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (10)
관련 논문AI추천
Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”Jong Young Choi, Soon Kyu Lee대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”Amal Magdy, Hee-Jin Kim, Mirang Kim, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Gut microbiome and metabolome signatures in liver cirrhosis-related complications양동훈, Dong Joon Kim, Goo-Hyun Kwon, Gwang Ho Baik, Haripriya Gupta, Hyunjoon Park, Jeong Ha Park, Jeoung Su Kim, Jin-Ju Jeong, Jung A Eom, Ki-Kwang Oh, Ki Tae Suk, Kyeong Jin Lee, Min Ju Kim, Sang Jun Yoon, Sang Yoon Lee, Satya Priya Sharma, Seol Hee Song, Sung-Min Won, Young Lim Ham대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Jae Young Jang, Seung Up Kim, Tom Ryu, Young Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence on Editorial regarding “Baveno- VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”Giulia Tosetti, Massimo Primignani, Sanchit Sharma, Xiaolong Qi, Yu Jun Wong대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Correspondence to editorial 2 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”Haiyu Wang, Jinjun Chen대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (84건)
Roles of X-box binding protein 1 in liver pathogenesisYun Seok Kim, Jihoon Tak, Sang Geon Kimpp. 1-31Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screeningTian Xia, Jiawen Wangpp. 1-2KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025Eun Joo Lee, Jung Hee Kim, Byoung Kuk Jang, Miyoung Choi, Su Jong Yu, Young-Sun Lee, Young-Joo Jin, Hye Won Lee, Soon Sun Kim, Pil Soo Sung, Young Kul Jung, Gi-Ae Kim, Young Chang, Won Sohn, Jeong-ju Yoopp. 1-31Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHua Lu, Xiao-Song Li, Xi-Ping Shen, Hang Lipp. 3-4Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adultsDonghee Kim, Aijaz Ahmed, Won Kimpp. 5-7